A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria

BMC Nephrology

Research Article

Pisut Katavetin¹  Somchai Eiam-Ong¹  Sadudee Peerapornratana¹  Nattachai Srisawat¹  Paweena Susantitaphong¹  Khajohn Tiranathanagul¹  Kearkiat Praditpornsilpa¹  Siriwan Nakwan¹ 

[1] Division of Nephrology, Department of Medicine, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University, 1873, Rama 4 Rd., Pathumwan, 10330, Bangkok, Thailand;

关键词: Vitamin D deficiency;    CKD;    Proteinuria;    Ergocalciferol;    Calcitriol;   

DOI  :  10.1186/s12882-017-0436-6

 received in 2015-11-20, accepted in 2017-01-04,  发布年份 2017

来源: Springer

【 摘 要 】

BackgroundKDOQI guideline suggests that nutritional vitamin D should be supplemented in chronic kidney disease (CKD) patients who have vitamin D insufficiency/deficiency. However, there are scarce data regarding the additional benefit of active vitamin D supplement in CKD patients who were receiving nutritional vitamin D supplement. This study was conducted to explore the effect of adding active vitamin D to nutritional vitamin D supplement on proteinuria and kidney function in CKD with vitamin D insufficiency/deficiency.MethodsThis double-blind, randomized placebo-controlled trial was performed to answer the above question. Sixty-eight patients with CKD stage 3–4, urine protein to creatinine ratio (UPCR) > 1 g/g, and serum 25OH-D level < 30 ng/mL were enrolled. Patients were randomly assigned to receive 12-week treatment with oral ergocalciferol plus placebo (n = 36) or oral ergocalciferol plus calcitriol (n = 32).ResultsThe mean baseline values of UPCR of both groups were comparable (3.6 ± 3.8 g/g in combined group and 3.5 ± 3.0 g/g in ergocalciferol group). Following 12-week treatment, there were significant reductions in UPCR from baseline in both groups (2.3 ± 2.1 g/g in combined group and 2.4 ± 2.0 g/g in ergocalciferol group). The percentage reductions in UPCR of both groups were not significantly different. The mean eGFR and blood pressure did not differ between baseline and 12-week follow-up and between both groups. No severe hypercalcemia or serious side effects were noted in both groups.ConclusionsThe proteinuria lowering effect of ergocalciferol in CKD patients with vitamin D deficiency was demonstrated. Additional calcitriol supplement did not have more effects on proteinuria.Trial registration(Thai Clinical Trials Registry (TCTR) 20140929002). Date of registration: September 27, 2014.

【 授权许可】

CC BY   
© The Author(s). 2017